Clinical Evaluation of a Treatment Planning Software and Oncology Information System for Proton Therapy
NCT07759999 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2026-08-12
Summary
Researchers are doing this study to better understand how certain treatment planning and clinical workflow software systems support the delivery of standard-of-care proton radiation therapy.
The main question it aims to answer is how well the software works in the workflow.
Participants will receive proton therapy.
Conditions
- Proton Therapy
Interventions
- DEVICE
-
Treatment Planning Software
Uniform application of RayTracker and RayAdaptive software analyses for every verification image taken during proton therapy.
Sponsors & Collaborators
-
University of Wisconsin, Madison
lead OTHER
Principal Investigators
-
Benjamin Durkee, MD, PhD · University of Wisconsin, Madison
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-15
- Primary Completion
- 2027-09-30
- Completion
- 2027-09-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
NCT05477823 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer
NCT00003104 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
NCT00258466 ·Status: WITHDRAWN ·Phase: PHASE3
-
Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer
NCT00084526 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate
NCT00585962 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer
NCT01230866 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer
NCT01839994 ·Status: UNKNOWN ·Phase: PHASE3
-
Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma
NCT02264379 ·Status: COMPLETED
-
Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer
NCT01352429 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer
NCT00831623 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
NCT00002602 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Proton Therapy Patient Registry
NCT02986048 ·Status: RECRUITING
-
Virtual Environment Radiotherapy to Improve Patients' Compliance to Radiotherapy (RT) in Prostate Cancer
NCT03326440 ·Status: COMPLETED ·Phase: NA
-
Prostate Cancer Parameters for Patients Receiving Proton Treatment
NCT02110849 ·Status: WITHDRAWN
-
Hypofractionated WPPT With HDR Boost
NCT06591819 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer
NCT00921193 ·Status: COMPLETED ·Phase: NA
-
Phase I/II Hypofractionated Radiotherapy for Prostate Cancer
NCT00214097 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Proton Therapy for High Risk Prostate Cancer
NCT01811810 ·Status: WITHDRAWN ·Phase: NA
-
Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer
NCT02470897 ·Status: COMPLETED ·Phase: NA
-
Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer
NCT03624660 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion
NCT01913717 ·Status: UNKNOWN ·Phase: NA
-
Study of Treatment Choice in Patients With Localized Prostate Cancer
NCT01177865 ·Status: UNKNOWN ·Phase: NA
-
Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial
NCT07130682 ·Status: RECRUITING ·Phase: NA
-
Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases
NCT05106699 ·Status: RECRUITING ·Phase: NA
-
Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning
NCT02681614 ·Status: COMPLETED ·Phase: NA